// App-Quantinova.ai

940 : Incidence of Central Nervous System (CNS) Relapse in De Novo Adult Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Deborah A. Thomas

Principal Investigators

  • Susan -Brien

  • Michael Rytting

  • Michael Andreeff

  • Steven M. Kornblau

  • Srdan Verstovsek

  • Farhad Ravandi

  • Elias Jabbour

  • Alessandra Ferrajoli

  • Zeev Estrov

  • Guillermo Garcia-Manero

  • Jan A. Burger

  • William Wierda

  • Marina Konopleva

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Lactate dehydrogenase

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Methotrexate

  • Vincristine

  • Doxorubicin

  • Cytarabine liposomal

  • Inotuzumab ozogamicin

  • Nelarabine

  • ofatumumab Intravenous

  • Ponatinib

  • Rituximab

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

  • ara-c

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved